Coherus Awaits August 2022 Date As FDA Accepts Ranibizumab Biosimilar

Company Set For Showdown With Samsung Bioepis For Biosimilar Lucentis

 
• By Dean Rudge
  
FDASignBldg21Entrance_1200x675
Samsung Bioepis' Byooviz became the first FDA-approved Lucentis biosimilar last month • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products